| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.9 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.032 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.03 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |